Fujirebio

Fujirebio Inc., a leading diagnostic company based in Japan, has received approval from China’s National Medical Products Administration (NMPA) for its innovative hepatitis B virus surface antigen (HBsAg) detection kit, which utilizes the chemiluminescence method. This detection kit, comprising antibody binding particles, enzyme-labeled antibodies, and a sample processing solution, is…